Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Bulk Drug Intermediates >  5-Methyl-3,4-diphenylisoxazole

5-Methyl-3,4-diphenylisoxazole

Basic information Safety Supplier Related

5-Methyl-3,4-diphenylisoxazole Basic information

Product Name:
5-Methyl-3,4-diphenylisoxazole
Synonyms:
  • Valdecoxib Impurity 10 (Desulfonamide)
  • 4-diphenyl-(Parecoxib sodiuM inteMediate)
  • 5-Methyl-3
  • Parecoxib impurity 5/5-methyl-3,4-diphenylisoxazole
  • Isoxazole, 5-Methyl-3,4-diphenyl- (Parecoxib sodiuM inteMediate)
  • Isoxazole, 5-Methyl-3,4-diphenyl-
  • 3,4-Diphenyl-5-methylisoxazole
  • 5-Methyl-3,4-diphenylisoxazole
CAS:
37928-17-9
MF:
C16H13NO
MW:
235.28
EINECS:
1592732-453-0
Product Categories:
  • API
Mol File:
37928-17-9.mol
More
Less

5-Methyl-3,4-diphenylisoxazole Chemical Properties

Melting point:
96.0 to 100.0 °C
Boiling point:
340.1±21.0 °C(Predicted)
Density 
1.108±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
solubility 
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
form 
Solid
pka
-2.53±0.50(Predicted)
color 
White to Off-White
InChIKey
ZXIRUKJWLADSJS-UHFFFAOYSA-N
More
Less

Safety Information

HS Code 
2934.99.4400
More
Less

5-Methyl-3,4-diphenylisoxazole Usage And Synthesis

Uses

5-Methyl-3,4-diphenylisoxazole is synthesis The key intermediate of Parecoxib Sodium (Parecoxib Sodium).Parecoxib Sodium is by the Pfizer of the U.S. The cox 2 inhibitor of company's research and development, listed in European Union in 2002, trade name Dynastat, is used for The short term therapy of postoperative pain.

Uses

5-Methyl-3,4-diphenylisoxazole is a reagent for the preparation of valdecoxib and valdecoxib analogues.

Synthesis


In four mouthfuls of round-bottomed flasks of a 1L add compound 2 (40g), methanol (400mL), 7.7% Aqueous sodium carbonate (400mL), is heated to 70 DEG C, after stirring reaction 2h, and TLC plate monitoring raw material Fundamental reaction is complete, and solution is divided into solid-liquid biphase, is extracted with ethyl acetate, collected organic layer, with anhydrous Sodium sulfate is dried, and vacuum obtains white solid, HPLC purity: 94.9% after being spin-dried for.White solid uses 40ml ethyl acetate and the mixed solvent recrystallization of 120ml normal hexane (1:3) again, Obtaining target compound is white solid 34.2g, yield 92%, HPLC purity: 99.7%.m.p.97-98??£? MS(m/z):236(M+H)+£?1H NMR(400MHz,CDCl3) |?:2.43(s,3H,-CH3), 7.19-7.43 (m, 10H ,-CH=).

5-Methyl-3,4-diphenylisoxazoleSupplier

Shanghai Famo Bio-chemical Technology Company Ltd. Gold
Tel
+862136680027 15800370750
Email
sales@famobiotech.com
Jiangsu Vcare PharmaTech Co., Ltd. Gold
Tel
025-58741518; 18013018875
Email
sales@vcarepharmatech.com
Chengdu Climb Pharmaceutical Technology Co., Ltd. Gold
Tel
028-87608726 13540107218
Email
sales@cdclimb.com
Shandong RuiYue Biotechnology Co., Ltd. Gold
Tel
0531-88581623 18805314509
Email
1456922171@126.com
TIANJIN PHARMACN MEDICAL TECHNOLOGY CO.,LTD.
Tel
022-60182192,1339732154 18722583064
Email
marketing@pharmacn.com